Bausch Health (XSWX:VRX) Interest Expense : CHF-1,190 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bausch Health's interest expense for the three months ended in Dec. 2023 was CHF -314 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-1,190 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bausch Health's Operating Income for the three months ended in Dec. 2023 was CHF 435 Mil. Bausch Health's Interest Expense for the three months ended in Dec. 2023 was CHF -314 Mil. Bausch Health's Interest Coverage for the quarter that ended in Dec. 2023 was 1.39. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bausch Health Interest Expense Historical Data

The historical data trend for Bausch Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Interest Expense Chart

Bausch Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1,583.95

-1,362.81

-1,313.35

-1,363.86

-1,148.45

Bausch Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-286.00	-284.13	-287.23	-304.96	-313.92

Bausch Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-1,190 Mil.

Bausch Health (XSWX:VRX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bausch Health's Interest Expense for the three months ended in Dec. 2023 was CHF-314 Mil. Its Operating Income for the three months ended in Dec. 2023 was CHF435 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was CHF18,972 Mil.

Bausch Health's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	434.994	/	-313.922
	=	1.39

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Bausch Health Companies Inc interest coverage is 1.2, which is low.

Bausch Health (XSWX:VRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany BHC:Canada

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (XSWX:VRX) Headlines

No Headlines